长江生命科技(00775)发布年度业绩,股东应占亏损1.87亿港元 同比增加47.61%

智通财经
Mar 17

智通财经APP讯,长江生命科技(00775)发布2025年度业绩,该集团取得收入54.1亿港元,同比减少2%;公司股东权益应占亏损1.87亿港元,同比增加47.61%;每股亏损1.94港仙。

2025年度的股东应占亏损较2024年度增加6020万港元,当中反映研发开支增加6650万港元,以及数项非现金的特殊项目及一次性项目,包括葡萄园资产组合估值取得较大跌幅、数项拨备,以及有关从事研发的附属公司 Polynoma与纳斯达克上市公司TransCode Therapeutics( NAZ) 的交易收益。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10